Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]

DRUG2 trials

Sponsors

University of Maryland, Baltimore, University of Illinois at Chicago

Conditions

Coinfection, HIVHepatitis CHepatitis C Virus Infection, Response to Therapy ofHivSubstance Use Disorders

Phase 4

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

WithdrawnNCT03381859

University of Maryland, BaltimoreHepatitis C Virus Infection, Response to Therapy of

Start: 2019-12-01End: 2020-06-01Updated: 2020-04-20

Unknown Phase

Zepatier in Patients with Substance Use

CompletedNCT04048850

University of Illinois at ChicagoCoinfection, HIV, Hepatitis C, Hiv +1

Start: 2019-09-20End: 2022-09-09Updated: 2025-01-28